Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-072075)

Filing Details

Accession Number:: 0001209191-14-072075
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-01 21:26:27
Reporting Period:: 2014-11-28

Filing Date:: 2014-12-01
Accepted Time:: 2014-12-01 21:26:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597583	Daniel L Browne	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-28	6,000	$16.67	172,626	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Direct
Common Stock	409	Indirect	See footnote

Footnotes

1,000 shares acquired by the Reporting Person under the Issuer 2014 Employee Stock Purchase Plan on June 30, 2014.
These shares are held by the Dan and Brenda Browne Living Trust. Mr. Browne is a Trustee of the Dan and Brenda Browne Living Trust.